Search filters

List of works by Srihari Gopal

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia.

scientific article published on 8 July 2010

A Post-hoc comparison of paliperidone palmitate to oral risperidone during initiation of long-acting risperidone injection in patients with acute schizophrenia ⬇️

scientific article published on August 1, 2011

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia ⬇️

scientific article published on March 28, 2012

An Analysis of Potentially Prolactin-Related Adverse Events and Abnormal Prolactin Values in Randomized Clinical Trials with Paliperidone Palmitate ⬇️

scientific article published on 04 September 2012

Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases

scientific article

Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE).

scientific article published on 22 June 2011

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia.

scientific article

Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies

scientific article published on 19 June 2020

Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data

scientific article

Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks' Treatment in Patients with Clinically Stable Schizophrenia

scientific article published on 23 December 2020

Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies

scientific article published on 01 November 2019

Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population

article by Adam J Savitz et al published 2019 in Neuropsychiatric Disease and Treatment

Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose ⬇️

scientific article published on May 20, 2013

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study

scientific article published on 06 March 2020

Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference

scientific article

Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophrenia ⬇️

scientific article published on March 8, 2011

Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia

scientific article published on 5 June 2016

Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire

scientific article published on 02 July 2020

Personal and social functioning in schizophrenia: defining a clinically meaningful measure of maintenance in relapse prevention

scientific article published in June 2010

Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia

scientific article published on February 2010

Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate

scientific article published on 25 October 2018

Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia ⬇️

scientific article published on March 23, 2012

Paulina is supported by:

About Paulina

Help